Your browser doesn't support javascript.
loading
Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II study.
Lu, Shun; Zhou, Jian-Ying; Niu, Xiao-Min; Zhou, Jian-Ya; Jian, Hong; Yin, Hong-Yan; Guan, Sha; Wang, Lin-Fang; Li, Ke; He, James; Su, Wei-Guo.
Afiliación
  • Lu S; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zhou JY; The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Niu XM; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zhou JY; The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Jian H; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Yin HY; Hutchison MediPharma, Shanghai, China.
  • Guan S; Hutchison MediPharma, Shanghai, China.
  • Wang LF; Hutchison MediPharma, Shanghai, China.
  • Li K; Hutchison MediPharma, Shanghai, China.
  • He J; Hutchison MediPharma, Shanghai, China.
  • Su WG; Hutchison MediPharma, Shanghai, China.
Transl Lung Cancer Res ; 10(2): 839-854, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33718026
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Transl Lung Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Transl Lung Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China